ROIV SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000895421-26-000250
ROIV filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.3% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Roivant Sciences Ltd. The filing indicates a change in the holder's ownership stake, though specific details are not disclosed in the available text.
Key details
How ROIV stock reacted
Close before
$36.16
Aug 12, 2026
First close after
+0.33%
$36.28
5 trading days
+3.43%
$37.40
Since filing
+7.52%
$38.88
✦ Ask GOAX AI about this filing — what it means for ROIV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ROIV?
Click hereFrequently asked questions
What did ROIV file with the SEC on Aug 13, 2026?
ROIV filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Roivant Sciences Ltd. The filing indicates a change in the holder's ownership stake, though specific details are not disclosed in the available text.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ROIV stock react to this filing?
ROIV closed at $36.16 before the filing and $36.28 on Aug 13, 2026 (+0.33%). Five trading days later: $37.40 (+3.43%).
Other ROIV SEC filings
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 8-K · Fda approvalOct 21, 2026
- 8-K · SEC filingSep 18, 2026
- 8-K · Fda approvalSep 8, 2026
- 8-K · Fda approvalAug 28, 2026
- 8-K · Fda approvalAug 27, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- DEF 14A · Board changeJul 29, 2026
Get alerts when ROIV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days